Home

green

Ferring to Present New Data Analyses at IDWeek 2023 for REBYOTA® (fecal microbiota, live – jslm)

Read More

green

First Bladder Cancer Patient Dosed with Commercially Available Intravesical Gene Therapy ADSTILADRIN® (nadofaragene firadenovec-vncg)

Read More

green

Royalty Pharma and Ferring Pharmaceuticals enter into US $500 million royalty agreement for new intravesical gene therapy Adstiladrin® (nadofaragene firadenovec-vncg)

Read More

green

Largest integrated safety analysis for REBYOTA® (fecal microbiota, live – jslm) published in TAG

Read More

blue

ADSTILADRIN® Early Experience Program to Begin September 2023

Read More

blue

Ferring Receives U.S. FDA Approval of Drug Substance Manufacturing Scale-up Process for ADSTILADRIN®

Read More

blue

Ferring Announces Positive Topline Phase 3 Results for SI-6603

Read More

green

Four Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm) Presented at DDW 2023

Read More

Previous

Next

Life-changing therapies to help people build families and live better lives

At Ferring, we are committed to helping people build families and live better lives. In the United States, Ferring is a leader in reproductive medicine and maternal health, uro-oncology and in specialty areas within gastroenterology, including microbiome therapeutics, and orthopaedics.

icon box image

People & Families

click the edit button to change this text.
icon box image

Science & Innovation

click the edit button to change this text.

Believing in the power of research

Each of us at Ferring contribute to providing innovative solutions to help people live better lives. We devote significant research and development investment to new therapeutics, life cycle management and next generation healthcare solutions.

Join us

At Ferring Pharmaceuticals we highly value an attractive working environment that motivates our employees and stimulates the creative abilities and initiative of both individuals and teams. With over 6,000 employees in more than 50 countries, we are able to draw upon a large multicultural setting to enrich the work of our staff on all levels.

icon box image

Join us

click the edit button to change this text.
icon box image

About Ferring

click the edit button to change this text.

Helping people live better lives

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives.

Ferring is a leader in reproductive medicine and maternal health, uro-oncology and in specialty areas within gastroenterology, including microbiome therapeutics, and orthopaedics.

News